NCT03444402View on ClinicalTrials.gov

A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 2, 2018

Primary Completion Date

May 4, 2018

Study Completion Date

May 4, 2018

Conditions
GERD
Interventions
DRUG

CKD-381(formulation I)

1 tablet administered before the breakfast during 7 days

DRUG

CKD-381(formulation II)

1 tablet administered before the breakfast during 7 days

DRUG

D026(Nexium 40mg)

1 tablet administered before the breakfast during 7 days

Trial Locations (1)

Unknown

Seoul University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03444402 - A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter